Global Cell Therapy CMO Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,480	151 Pages	GlobalInfoResearch	April, 2025	GFSH19991996

Best Price Guarantee
Price	from $3,480
Length	151 Pages
Publisher	GlobalInfoResearch
Published Date	April, 2025
SKU	GFSH19991996

According to our (Global Info Research) latest study, the global Cell Therapy CMO market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report is a detailed and comprehensive analysis for global Cell Therapy CMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Cell Therapy CMO market size and forecasts, in consumption value ($ Million), 2020-2031

Global Cell Therapy CMO market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Cell Therapy CMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Cell Therapy CMO market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Cell Therapy CMO

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Cell Therapy CMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Cell Therapy CMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Stem Cell
Non-Stem Cell

Market segment by Application
Commercial
Academic Research
Others

Market segment by players, this report covers
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Cell Therapy CMO product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Cell Therapy CMO, with revenue, gross margin, and global market share of Cell Therapy CMO from 2020 to 2025.

Chapter 3, the Cell Therapy CMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell Therapy CMO market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Therapy CMO.

Chapter 13, to describe Cell Therapy CMO research findings and conclusion.

1 Market Overview: 1.1 Product Overview and Scope; 1.2 Market Estimation Caveats and Base Year; 1.3 Classification of Cell Therapy CMO by Type; 1.3.1 Overview: Global Cell Therapy CMO Market Size by Type: 2020 Versus 2024 Versus 2031; 1.3.2 Global Cell Therapy CMO Consumption Value Market Share by Type in 2024; 1.3.3 Stem Cell; 1.3.4 Non-Stem Cell; 1.4 Global Cell Therapy CMO Market by Application; 1.4.1 Overview: Global Cell Therapy CMO Market Size by Application: 2020 Versus 2024 Versus 2031; 1.4.2 Commercial; 1.4.3 Academic Research; 1.4.4 Others; 1.5 Global Cell Therapy CMO Market Size & Forecast; 1.6 Global Cell Therapy CMO Market Size and Forecast by Region; 1.6.1 Global Cell Therapy CMO Market Size by Region: 2020 VS 2024 VS 2031; 1.6.2 Global Cell Therapy CMO Market Size by Region, (2020-2031); 1.6.3 North America Cell Therapy CMO Market Size and Prospect (2020-2031); 1.6.4 Europe Cell Therapy CMO Market Size and Prospect (2020-2031); 1.6.5 Asia-Pacific Cell Therapy CMO Market Size and Prospect (2020-2031); 1.6.6 South America Cell Therapy CMO Market Size and Prospect (2020-2031); 1.6.7 Middle East & Africa Cell Therapy CMO Market Size and Prospect (2020-2031)
2 Company Profiles: 2.1 Charles River; 2.1.1 Charles River Details; 2.1.2 Charles River Major Business; 2.1.3 Charles River Cell Therapy CMO Product and Solutions; 2.1.4 Charles River Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.1.5 Charles River Recent Developments and Future Plans; 2.2 The Discovery Labs; 2.2.1 The Discovery Labs Details; 2.2.2 The Discovery Labs Major Business; 2.2.3 The Discovery Labs Cell Therapy CMO Product and Solutions; 2.2.4 The Discovery Labs Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.2.5 The Discovery Labs Recent Developments and Future Plans; 2.3 BIOCENTRIQ; 2.3.1 BIOCENTRIQ Details; 2.3.2 BIOCENTRIQ Major Business; 2.3.3 BIOCENTRIQ Cell Therapy CMO Product and Solutions; 2.3.4 BIOCENTRIQ Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.3.5 BIOCENTRIQ Recent Developments and Future Plans; 2.4 FUJIFILM Diosynth Biotechnologies; 2.4.1 FUJIFILM Diosynth Biotechnologies Details; 2.4.2 FUJIFILM Diosynth Biotechnologies Major Business; 2.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product and Solutions; 2.4.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans; 2.5 Exothera; 2.5.1 Exothera Details; 2.5.2 Exothera Major Business; 2.5.3 Exothera Cell Therapy CMO Product and Solutions; 2.5.4 Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.5.5 Exothera Recent Developments and Future Plans; 2.6 WuXi AppTec; 2.6.1 WuXi AppTec Details; 2.6.2 WuXi AppTec Major Business; 2.6.3 WuXi AppTec Cell Therapy CMO Product and Solutions; 2.6.4 WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.6.5 WuXi AppTec Recent Developments and Future Plans; 2.7 Pharmaron; 2.7.1 Pharmaron Details; 2.7.2 Pharmaron Major Business; 2.7.3 Pharmaron Cell Therapy CMO Product and Solutions; 2.7.4 Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.7.5 Pharmaron Recent Developments and Future Plans; 2.8 OBiO; 2.8.1 OBiO Details; 2.8.2 OBiO Major Business; 2.8.3 OBiO Cell Therapy CMO Product and Solutions; 2.8.4 OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.8.5 OBiO Recent Developments and Future Plans; 2.9 Cell Therapies; 2.9.1 Cell Therapies Details; 2.9.2 Cell Therapies Major Business; 2.9.3 Cell Therapies Cell Therapy CMO Product and Solutions; 2.9.4 Cell Therapies Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.9.5 Cell Therapies Recent Developments and Future Plans; 2.10 AGC Biologics; 2.10.1 AGC Biologics Details; 2.10.2 AGC Biologics Major Business; 2.10.3 AGC Biologics Cell Therapy CMO Product and Solutions; 2.10.4 AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.10.5 AGC Biologics Recent Developments and Future Plans; 2.11 Cytiva; 2.11.1 Cytiva Details; 2.11.2 Cytiva Major Business; 2.11.3 Cytiva Cell Therapy CMO Product and Solutions; 2.11.4 Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.11.5 Cytiva Recent Developments and Future Plans; 2.12 Helixmith; 2.12.1 Helixmith Details; 2.12.2 Helixmith Major Business; 2.12.3 Helixmith Cell Therapy CMO Product and Solutions; 2.12.4 Helixmith Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.12.5 Helixmith Recent Developments and Future Plans; 2.13 ThermoGenesis; 2.13.1 ThermoGenesis Details; 2.13.2 ThermoGenesis Major Business; 2.13.3 ThermoGenesis Cell Therapy CMO Product and Solutions; 2.13.4 ThermoGenesis Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.13.5 ThermoGenesis Recent Developments and Future Plans; 2.14 Anemocyte; 2.14.1 Anemocyte Details; 2.14.2 Anemocyte Major Business; 2.14.3 Anemocyte Cell Therapy CMO Product and Solutions; 2.14.4 Anemocyte Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.14.5 Anemocyte Recent Developments and Future Plans; 2.15 Thermo Fisher Scientific; 2.15.1 Thermo Fisher Scientific Details; 2.15.2 Thermo Fisher Scientific Major Business; 2.15.3 Thermo Fisher Scientific Cell Therapy CMO Product and Solutions; 2.15.4 Thermo Fisher Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans; 2.16 CBM; 2.16.1 CBM Details; 2.16.2 CBM Major Business; 2.16.3 CBM Cell Therapy CMO Product and Solutions; 2.16.4 CBM Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.16.5 CBM Recent Developments and Future Plans; 2.17 Bio Elpida; 2.17.1 Bio Elpida Details; 2.17.2 Bio Elpida Major Business; 2.17.3 Bio Elpida Cell Therapy CMO Product and Solutions; 2.17.4 Bio Elpida Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.17.5 Bio Elpida Recent Developments and Future Plans; 2.18 Genezen; 2.18.1 Genezen Details; 2.18.2 Genezen Major Business; 2.18.3 Genezen Cell Therapy CMO Product and Solutions; 2.18.4 Genezen Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.18.5 Genezen Recent Developments and Future Plans; 2.19 CCRM; 2.19.1 CCRM Details; 2.19.2 CCRM Major Business; 2.19.3 CCRM Cell Therapy CMO Product and Solutions; 2.19.4 CCRM Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.19.5 CCRM Recent Developments and Future Plans; 2.20 RoslinCT; 2.20.1 RoslinCT Details; 2.20.2 RoslinCT Major Business; 2.20.3 RoslinCT Cell Therapy CMO Product and Solutions; 2.20.4 RoslinCT Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.20.5 RoslinCT Recent Developments and Future Plans; 2.21 GenScript ProBio; 2.21.1 GenScript ProBio Details; 2.21.2 GenScript ProBio Major Business; 2.21.3 GenScript ProBio Cell Therapy CMO Product and Solutions; 2.21.4 GenScript ProBio Cell Therapy CMO Revenue, Gross Margin and Market Share (2020-2025); 2.21.5 GenScript ProBio Recent Developments and Future Plans
3 Market Competition, by Players: 3.1 Global Cell Therapy CMO Revenue and Share by Players (2020-2025); 3.2 Market Share Analysis (2024); 3.2.1 Market Share of Cell Therapy CMO by Company Revenue; 3.2.2 Top 3 Cell Therapy CMO Players Market Share in 2024; 3.2.3 Top 6 Cell Therapy CMO Players Market Share in 2024; 3.3 Cell Therapy CMO Market: Overall Company Footprint Analysis; 3.3.1 Cell Therapy CMO Market: Region Footprint; 3.3.2 Cell Therapy CMO Market: Company Product Type Footprint; 3.3.3 Cell Therapy CMO Market: Company Product Application Footprint; 3.4 New Market Entrants and Barriers to Market Entry; 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type: 4.1 Global Cell Therapy CMO Consumption Value and Market Share by Type (2020-2025); 4.2 Global Cell Therapy CMO Market Forecast by Type (2026-2031)
5 Market Size Segment by Application: 5.1 Global Cell Therapy CMO Consumption Value Market Share by Application (2020-2025); 5.2 Global Cell Therapy CMO Market Forecast by Application (2026-2031)
6 North America: 6.1 North America Cell Therapy CMO Consumption Value by Type (2020-2031); 6.2 North America Cell Therapy CMO Market Size by Application (2020-2031); 6.3 North America Cell Therapy CMO Market Size by Country; 6.3.1 North America Cell Therapy CMO Consumption Value by Country (2020-2031); 6.3.2 United States Cell Therapy CMO Market Size and Forecast (2020-2031); 6.3.3 Canada Cell Therapy CMO Market Size and Forecast (2020-2031); 6.3.4 Mexico Cell Therapy CMO Market Size and Forecast (2020-2031)
7 Europe: 7.1 Europe Cell Therapy CMO Consumption Value by Type (2020-2031); 7.2 Europe Cell Therapy CMO Consumption Value by Application (2020-2031); 7.3 Europe Cell Therapy CMO Market Size by Country; 7.3.1 Europe Cell Therapy CMO Consumption Value by Country (2020-2031); 7.3.2 Germany Cell Therapy CMO Market Size and Forecast (2020-2031); 7.3.3 France Cell Therapy CMO Market Size and Forecast (2020-2031); 7.3.4 United Kingdom Cell Therapy CMO Market Size and Forecast (2020-2031); 7.3.5 Russia Cell Therapy CMO Market Size and Forecast (2020-2031); 7.3.6 Italy Cell Therapy CMO Market Size and Forecast (2020-2031)
8 Asia-Pacific: 8.1 Asia-Pacific Cell Therapy CMO Consumption Value by Type (2020-2031); 8.2 Asia-Pacific Cell Therapy CMO Consumption Value by Application (2020-2031); 8.3 Asia-Pacific Cell Therapy CMO Market Size by Region; 8.3.1 Asia-Pacific Cell Therapy CMO Consumption Value by Region (2020-2031); 8.3.2 China Cell Therapy CMO Market Size and Forecast (2020-2031); 8.3.3 Japan Cell Therapy CMO Market Size and Forecast (2020-2031); 8.3.4 South Korea Cell Therapy CMO Market Size and Forecast (2020-2031); 8.3.5 India Cell Therapy CMO Market Size and Forecast (2020-2031); 8.3.6 Southeast Asia Cell Therapy CMO Market Size and Forecast (2020-2031); 8.3.7 Australia Cell Therapy CMO Market Size and Forecast (2020-2031)
9 South America: 9.1 South America Cell Therapy CMO Consumption Value by Type (2020-2031); 9.2 South America Cell Therapy CMO Consumption Value by Application (2020-2031); 9.3 South America Cell Therapy CMO Market Size by Country; 9.3.1 South America Cell Therapy CMO Consumption Value by Country (2020-2031); 9.3.2 Brazil Cell Therapy CMO Market Size and Forecast (2020-2031); 9.3.3 Argentina Cell Therapy CMO Market Size and Forecast (2020-2031)
10 Middle East & Africa: 10.1 Middle East & Africa Cell Therapy CMO Consumption Value by Type (2020-2031); 10.2 Middle East & Africa Cell Therapy CMO Consumption Value by Application (2020-2031); 10.3 Middle East & Africa Cell Therapy CMO Market Size by Country; 10.3.1 Middle East & Africa Cell Therapy CMO Consumption Value by Country (2020-2031); 10.3.2 Turkey Cell Therapy CMO Market Size and Forecast (2020-2031); 10.3.3 Saudi Arabia Cell Therapy CMO Market Size and Forecast (2020-2031); 10.3.4 UAE Cell Therapy CMO Market Size and Forecast (2020-2031)
11 Market Dynamics: 11.1 Cell Therapy CMO Market Drivers; 11.2 Cell Therapy CMO Market Restraints; 11.3 Cell Therapy CMO Trends Analysis; 11.4 Porters Five Forces Analysis; 11.4.1 Threat of New Entrants; 11.4.2 Bargaining Power of Suppliers; 11.4.3 Bargaining Power of Buyers; 11.4.4 Threat of Substitutes; 11.4.5 Competitive Rivalry
12 Industry Chain Analysis: 12.1 Cell Therapy CMO Industry Chain; 12.2 Cell Therapy CMO Upstream Analysis; 12.3 Cell Therapy CMO Midstream Analysis; 12.4 Cell Therapy CMO Downstream Analysis
13 Research Findings and Conclusion
14 Appendix: 14.1 Methodology; 14.2 Research Process and Data Source; 14.3 Disclaimer

PDF E-mail From Publisher:	$3,480
Multi User License (1-20) Fulfilled by Publisher:	$5,220
Global Site License Fulfilled by Publisher:	$6,960

Show additional purchase options...

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Global Cell Therapy CMO Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Cell Therapy and Acellular Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Cell Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global NK Cell Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global iPSC Cell Therapies Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Orthopedic Cell Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global CAR T-Cell Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Research Assistance

Other tasks